1. Bollag G, Freeman S, Lyons JF, Post LE (2003) Raf pathway inhibitors in oncology. Curr Opin Investig Drugs 4:1436?1441
2. Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49:4682?4689
3. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949?954
4. Ding H, Roncari L, Shannon P, Wu X, Lau N, Karaskova J, Gutmann DH, Squire JA, Nagy A, Guha A (2001) Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res 61:3826?3836
5. Downward J (2003) Targeting RAS signaling pathways in cancer therapy. Nat Rev Cancer 3:11?22